Keywords: تولوپتان; Heart failure; Echocardiography; Tolvaptan; Right ventricle; Drug responder;
مقالات ISI تولوپتان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تولوپتان; Overcorrection; tolvaptan; hyponatremia; serum sodium; kidney function; blood urea nitrogen (BUN); syndrome of inappropriate secretion of antidiuretic hormone (SIADH); congestive heart failure (CHF); osmolality; hypouremia;
Keywords: تولوپتان; GuÃa clÃnica; Secreción inadecuada de ADH; Hormona antidiurética; Tolvaptan; SÃndrome de antidiuresis inapropiada; Clinical guidelines; SIADH; Antidiuretic hormone; Tolvaptan; Syndrome of inappropriate antidiuretic hormone secretion;
Keywords: تولوپتان; Heart failure; Chloride; Diuretics; Tolvaptan; Vasopressin antagonist;
Keywords: تولوپتان; Worsening renal function; Acute decompensated heart failure; Elderly; Tolvaptan; Furosemide
Keywords: تولوپتان; Fluid restriction; Hypertonic saline; Hyponatremia; Isotonic saline; Syndrome of inappropriate antidiuretic hormone secretion; Tolvaptan;
Keywords: تولوپتان; Autosomal dominant polycystic kidney disease (ADPKD); tolvaptan; vasopressin V2 receptor antagonist; drug efficacy; disease progression; kidney function; glomerular filtration rate (GFR);
Keywords: تولوپتان; Diuretics; Heart failure; Pulmonary hypertension; Renal dysfunction; Tolvaptan;
Keywords: تولوپتان; pharmacodynamics; pharmacokinetics; renal impairment; tolvaptan; vasopressin antagonist;
Keywords: تولوپتان; Aquaretic; Conivaptan; Diuretic; Dyspnea; EVEREST; Hyponatremia; Tolvaptan; Vasopressin antagonist;
Keywords: تولوپتان; Tolvaptan; Heart failure; Hyponatremia; Dyspnea; Randomized clinical trial
Limited Efficacy of Tolvaptan in Patients with Cirrhosis and Severe Hyponatremia: Real-Life Experience
Keywords: تولوپتان; Cirrhosis; Hypervolemic hyponatremia; Hyponatremia; Tolvaptan; Vasopressin;
Les nouveaux médicaments en néphrologie
Keywords: تولوپتان; néphrologie; oxyhydroxyde sucro-ferrique; tolvaptan; nephrology; sucroferric oxyhydroxide; tolvaptan;
Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial
Keywords: تولوپتان; Autosomal dominant polycystic kidney disease (ADPKD); pain; tolvaptan; vasopressin; acute kidney pain event; TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3:4; pain severity; analgesic
Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4
Keywords: تولوپتان; aquaretic adverse events; autosomal dominant polycystic kidney disease; discontinuation; drug safety; tolerability; tolvaptan;
Characterization of the phase I and phase II metabolic profile of tolvaptan by in vitro studies and liquid chromatography-mass spectrometry profiling: Relevance to doping control analysis
Keywords: تولوپتان; Tolvaptan; In vitro metabolism; LC-MS/(MS); Anti-Doping analysis; Drug-drug interactions; Azole antifungals;
Effects of short-term administration of tolvaptan after open heart surgery
Keywords: تولوپتان; Diuretics; Heart failure; Surgery; Tolvaptan;
Efficacy and safety of tolvaptan for pediatric patients with congestive heart failure. Multicenter survey in the working group of the Japanese Society of PEdiatric Circulation and Hemodynamics (J-SPECH)
Keywords: تولوپتان; Child; Congestive heart failure; Diuretics; Arginine vasopressin; Tolvaptan; Hyponatremia
A rapid and sensitive LC–MS/MS-ESI method for the determination of tolvaptan and its two main metabolites in human plasma
Keywords: تولوپتان; Tolvaptan; Metabolite; LC–MS/MS; Human plasma; Method validation
Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT)
Keywords: تولوپتان; Chronic hyponatremia; serum sodium; tolvaptan; vasopressin receptor antagonist; aquaresis; gait; postural stability; cognition; neurocognitive function; bone resorption; bone metabolism; osteoporosis; randomized controlled trial (RCT);
Quantification of tolvaptan in rabbit plasma by LC–MS/MS: Application to a pharmacokinetic study
Keywords: تولوپتان; Tolvaptan; LC–ESI–MS/MS; Rabbit plasma; Liquid–liquid extraction; Pharmacokinetics
Mechanisms of tolvaptan-induced toxicity in HepG2 cells
Keywords: تولوپتان; Tolvaptan; Liver injury; DNA damage; Apoptosis; Proteasome; Autophagy
Enantioselective analysis of tolvaptan in rat and dog sera by high-performance liquid chromatography and application to pharmacokinetic study
Keywords: تولوپتان; Tolvaptan; OPC-41061; Samska™
Cost-effectiveness of Tolvaptan for Euvolemic or Hypervolemic Hyponatremia
Keywords: تولوپتان; cost-effectiveness; decision-analytic model; hyponatremia; tolvaptan;
Successful treatment of congestive heart failure with concomitant administration of tolvaptan to enhance the effects of furosemide
Keywords: تولوپتان; Congestive heart failure; Fractional excretion of sodium; Free-water clearance; Furosemide; Tolvaptan
Development and validation of an LC–MS/MS method for the determination of tolvaptan in human plasma and its application to a pharmacokinetic study
Keywords: تولوپتان; Tolvaptan; LC–MS/MS; Human plasma; Pharmacokinetics
El tratamiento de la hiponatremia secundaria al sÃndrome de secreción inadecuada de la hormona antidiurética
Keywords: تولوپتان; SÃndrome de secreción inadecuada de vasopresina; Hiponatremia; EncefalopatÃa hiponatrémica; Hipoosmolalidad plasmática; Tolvaptán; Algoritmo; Consenso; Syndrome of inappropriate antidiuretic hormone secretion; Hyponatremia; Hyponatremic encephalopat
Hyponatremia in critical care patients: Frequency, outcome, characteristics, and treatment with the vasopressin V2-receptor antagonist tolvaptan
Keywords: تولوپتان; Critical care; Hyponatremia; ICU; SIADH; Tolvaptan;
Synthesis of the major metabolites of Tolvaptan
Keywords: تولوپتان; Tolvaptan; Metabolites; Synthesis
4 Perspectives on the management of hyponatraemia secondary to SIADH across Europe
Keywords: تولوپتان; endocrinology; fluid restriction; hypertonic saline; hyponatraemia nephrology; syndrome of inappropriate secretion of antidiuretic hormone (SIADH); tolvaptan
3 Considerations regarding the management of hyponatraemia secondary to SIADH
Keywords: تولوپتان; fluid restriction; hypertonic saline; hyponatraemia; osmotic demyelination; syndrome of inappropriate antidiuresis (SIAD); syndrome of inappropriate secretion of antidiuretic hormone (SIADH); tolvaptan; vasopressin inhibition
Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet
Keywords: تولوپتان; conivaptan; hyponatremia; tolvaptan
Short-term Efficacy and Safety of Vasopressin Receptor Antagonists for Treatment of Hyponatremia
Keywords: تولوپتان; Hyponatremia; Conivaptan; Tolvaptan; Lixivaptan; Satavaptan;
Hyponatremia: Case Vignettes
Keywords: تولوپتان; Beer potomania; thiazide; pregnancy; olfactory neuroblastoma; hypopituitarism; SIADH; conivaptan; tolvaptan; DDAVP; hypertonic saline
Double-Blind, Placebo-Controlled, Multicenter Trial of a Vasopressin V2-Receptor Antagonist in Patients with Schizophrenia and Hyponatremia
Keywords: تولوپتان; Hyponatremia; schizophrenia; tolvaptan; vasopressin V2-receptor antagonist
Vasopressin Antagonists as Aquaretic Agents for the Treatment of Hyponatremia
Keywords: تولوپتان; Conivaptan; Hyponatremia; Lixivaptan; Syndrome of inappropriate antidiuretic hormone secretion; Tolvaptan; Vasopressin antagonists
A flexible approach for the preparation of substituted benzazepines: Application to the synthesis of tolvaptan
Keywords: تولوپتان; Xanthate; Benzazepines; Beckmann rearrangement; Tolvaptan